Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06843707
What this trial is testing

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Who this might be right for
Lung CancerLungLung Cancer (NSCLC)+1 more
The First Affiliated Hospital of Guangzhou Medical University 2,500
Early research (Phase 1)Study completedNCT06186492
What this trial is testing

Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)
Wave Life Sciences USA, Inc. 47
Not applicableStudy completedNCT01240707
What this trial is testing

Pathophysiologic Changes in the Respiratory System After Fire Smoke Inhalation

Who this might be right for
Bronchial Asthma
Oslo University Hospital 40
Not applicableUnknownNCT01873092
What this trial is testing

AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
VA New York Harbor Healthcare System 100
Not applicableUnknownNCT00849836
What this trial is testing

Novel Biomarkers in Chronic Airway Diseases

Who this might be right for
AsthmaCOPD
Chonbuk National University 30
Testing effectiveness (Phase 2)Study completedNCT00192036
What this trial is testing

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 49
Not applicableStudy completedNCT05465811
What this trial is testing

Telerehabilitation on Physical and Mental Health of the Elderly in the Covid-19 Pandemic Context

Who this might be right for
Elderly Women
Paulista University 8
Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Testing effectiveness (Phase 2)Ended earlyNCT00205907
What this trial is testing

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Who this might be right for
Pulmonary Emphysema
Aeris Therapeutics 4
Not applicableStudy completedNCT02316392
What this trial is testing

Imaging and Understanding BOS in Lung Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome
Children's Hospital Medical Center, Cincinnati 6
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Not applicableUnknownNCT02965300
What this trial is testing

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis

Who this might be right for
Lung NeoplasmLung Disease
Chinese PLA General Hospital 230
Not applicableStudy completedNCT05191407
What this trial is testing

Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic

Who this might be right for
FearAnxietyCOVID-19
Zeliha Aytekin 301
Testing effectiveness (Phase 2)Study completedNCT04475107
What this trial is testing

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 113
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00000811
What this trial is testing

Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Who this might be right for
Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 690
Testing effectiveness (Phase 2)Study completedNCT02169271
What this trial is testing

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

Who this might be right for
Current SmokerFormer SmokerMultiple Pulmonary Nodules+1 more
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Next Page